Clinical trials Our clinical trials ADVANCE SC (Idiopathic Thrombocytopenia Purpura - (RECRUITMENT: CLOSED) Project Title ADVANCE SC Official Title A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and the Safety of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia Project Summary This is a phase 3, multicenter, randomized, double-blinded, placebo-controlled, parallel-group trial to evaluate the efficacy, safety, and effect on QoL/PRO of efgartigimod PH20 SC treatment in adult patients with primary ITP. Blood Disorder Idiopathic thrombocytopenic purpura Patient Recruitment Details Patient recruitment status: closed Number of Patients (Globally) Undetermined.